Dnanexus
Mountain View, US · Founded 2009 · Delaware corporation · 6 known investors
DNAnexus operates a cloud platform for managing, analyzing, and collaborating on multiomic and clinical data, supporting bioinformatics workflows, AI/ML analytics, and cohort analysis. It serves biomedical organizations including pharmaceutical companies, clinical diagnostics providers, academic medical centers, and biobanks, with built-in GxP and regulatory compliance.
AI & Machine LearningBiotechCloud ComputingData & Infrastructure
Founders & leadership
RD
Richard DalyExecutive
GA
George Asimenos, PhDinChief Product Officer
MG
Michael GoldbergNamed on SEC filing
NG
Nathaniel GoldhaberNamed on SEC filing
AS
Andreas SundquistNamed on SEC filing
KY
Krishna YeshwantNamed on SEC filing
GD
Geoff DuykNamed on SEC filing
Board
MG.png?width=800&height=800&name=Michael%20Goldberg%20headshot%20(1).png)
.png?width=800&height=800&name=Michael%20Goldberg%20headshot%20(1).png)
MICHAEL GOLDBERGBoard director
GD
GEOFF DUYKBoard director
KY

NG

HS
HANNES SMARASONBoard director
Investors · 6
Reported raises · per SEC filings
Form D private placements$30M disclosed across 2 rounds · 2013–2015
▶$15MraisedApr 2015 · 1 investors · ComputersRule 506(b)
▶$15MraisedApr 2015 · 1 investors · Computers
Rule 506(b)Officers, directors & promoters on the filing
- HANNES SMARASONDirector
- Richard DalyExecutive Officer, Director
- MICHAEL GOLDBERGDirector
- GEOFF DUYKDirector
- STEPHEN THAUExecutive Officer
- KRISHNA YESHWANTDirector
- NATHANIEL GOLDHABERDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15MraisedJan 2014 · 4 investors · BiotechnologyRule 506(b)
▶$15MraisedJan 2014 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael GoldbergDirector
- Nathaniel GoldhaberDirector
- Andreas SundquistExecutive Officer, Director
- Richard DalyExecutive Officer, Director
- Krishna YeshwantDirector
- Geoff DuykDirector
- Offering amount
- $15M
- Amount sold
- $15M
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware, 2009
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapIDbyDNA51 shared keywordsScalable, high throughput DNA sequencing platforms.
Netezza48 shared keywordsIBM is a global technology company whose business spans enterprise software (including Red Hat, HashiCorp, and Confluent), IT infrastructure such as mainframes, servers, and storage, and IT consulting services. The company is also investing heavily in quantum computing and AI-based enterprise offerings, including its Lightwell open-source software security clearinghouse and the Anderon quantum wafer foundry.
Oup44 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
Genomeweb34 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.
Companies competing with Dnanexus for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Dnanexus do?
- DNAnexus operates a cloud platform for managing, analyzing, and collaborating on multiomic and clinical data, supporting bioinformatics workflows, AI/ML analytics, and cohort analysis. It serves biomedical organizations including pharmaceutical companies, clinical diagnostics providers, academic medical centers, and biobanks, with built-in GxP and regulatory compliance.
- Who are Dnanexus's investors?
- Dnanexus's investors include Claremont Creek Ventures, Foresite Capital, GV (Google Ventures), K9 Ventures, Uncork Capital, Wireframe Ventures.
- How much funding has Dnanexus raised?
- Dnanexus has disclosed $30M raised across 2 rounds.
- Where is Dnanexus headquartered?
- Dnanexus is headquartered in Mountain View, US.

